Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4HBA1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 139 | 141 | PF00675 | 0.632 |
CLV_PCSK_KEX2_1 | 125 | 127 | PF00082 | 0.625 |
CLV_PCSK_KEX2_1 | 139 | 141 | PF00082 | 0.669 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.619 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.414 |
CLV_PCSK_PC1ET2_1 | 125 | 127 | PF00082 | 0.616 |
CLV_PCSK_PC1ET2_1 | 139 | 141 | PF00082 | 0.642 |
CLV_PCSK_PC1ET2_1 | 163 | 165 | PF00082 | 0.619 |
CLV_PCSK_PC1ET2_1 | 39 | 41 | PF00082 | 0.475 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.625 |
DOC_MAPK_gen_1 | 9 | 17 | PF00069 | 0.600 |
DOC_PP1_RVXF_1 | 123 | 130 | PF00149 | 0.529 |
DOC_PP1_RVXF_1 | 180 | 187 | PF00149 | 0.523 |
LIG_14-3-3_CanoR_1 | 11 | 17 | PF00244 | 0.564 |
LIG_14-3-3_CanoR_1 | 187 | 195 | PF00244 | 0.391 |
LIG_APCC_ABBAyCdc20_2 | 73 | 79 | PF00400 | 0.312 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.590 |
LIG_FHA_1 | 12 | 18 | PF00498 | 0.561 |
LIG_LIR_Gen_1 | 130 | 138 | PF02991 | 0.411 |
LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.573 |
LIG_LIR_Gen_1 | 59 | 68 | PF02991 | 0.313 |
LIG_LIR_Nem_3 | 130 | 134 | PF02991 | 0.490 |
LIG_LIR_Nem_3 | 35 | 41 | PF02991 | 0.635 |
LIG_LIR_Nem_3 | 59 | 63 | PF02991 | 0.313 |
LIG_LYPXL_S_1 | 68 | 72 | PF13949 | 0.476 |
LIG_LYPXL_yS_3 | 100 | 103 | PF13949 | 0.439 |
LIG_LYPXL_yS_3 | 69 | 72 | PF13949 | 0.370 |
LIG_PDZ_Class_2 | 192 | 197 | PF00595 | 0.396 |
LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.427 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.597 |
LIG_SUMO_SIM_anti_2 | 59 | 65 | PF11976 | 0.344 |
LIG_SUMO_SIM_par_1 | 13 | 18 | PF11976 | 0.630 |
LIG_TRAF2_1 | 118 | 121 | PF00917 | 0.402 |
LIG_TYR_ITIM | 67 | 72 | PF00017 | 0.450 |
LIG_UBA3_1 | 159 | 163 | PF00899 | 0.562 |
LIG_WRC_WIRS_1 | 20 | 25 | PF05994 | 0.583 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.691 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.492 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.435 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.445 |
MOD_PKA_2 | 186 | 192 | PF00069 | 0.491 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.534 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.391 |
MOD_SUMO_for_1 | 162 | 165 | PF00179 | 0.663 |
MOD_SUMO_for_1 | 45 | 48 | PF00179 | 0.606 |
TRG_DiLeu_BaEn_1 | 180 | 185 | PF01217 | 0.635 |
TRG_DiLeu_BaLyEn_6 | 37 | 42 | PF01217 | 0.344 |
TRG_DiLeu_BaLyEn_6 | 62 | 67 | PF01217 | 0.410 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.534 |
TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.728 |
TRG_ENDOCYTIC_2 | 5 | 8 | PF00928 | 0.556 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.455 |
TRG_ER_diArg_1 | 88 | 91 | PF00400 | 0.507 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6S8 | Leptomonas seymouri | 63% | 100% |
A0A0S4KIP5 | Bodo saltans | 37% | 99% |
A0A1X0PAY8 | Trypanosomatidae | 46% | 100% |
A0A3S7X8G4 | Leishmania donovani | 85% | 100% |
A4IAE9 | Leishmania infantum | 85% | 100% |
C9ZLU5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9B5H3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4Q2G2 | Leishmania major | 85% | 100% |